|
|
|
Insider
Information: |
Bienaime Jean Jacques |
Relationship: |
Director |
City: |
Palo Alto |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
7 |
|
Direct
Shares |
539,056 |
|
Indirect Shares
|
247,533 |
|
|
Direct
Value |
$43,131,096 |
|
|
Indirect Value
|
$21,938,850 |
|
|
Total
Shares |
786,589 |
|
|
Total
Value |
$65,069,946 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
1
|
1
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
1
|
1
|
|
|
|
Gain/Loss Ratio : |
-1.0
|
-1.0
|
Percentage
Gain/Loss : |
-34.0%
|
-5.5%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Biomarin Pharmaceutical Inc |
BMRN |
Director |
2024-05-10 |
474,994 |
2024-05-10 |
247,533 |
Premium* |
|
Neurogesx Inc |
NGSX |
Director |
2011-07-26 |
21,748 |
|
0 |
Premium* |
|
InterMune Inc |
ITMN |
Director |
2014-09-29 |
0 |
2012-04-06 |
0 |
Premium* |
|
Portola Pharmaceuticals Inc |
PTLA |
Director |
2014-05-16 |
706 |
2013-05-28 |
0 |
Premium* |
|
Immunic Inc |
IMUX |
Director |
2018-09-24 |
18,500 |
2001-04-23 |
0 |
Premium* |
|
Incyte Corp |
INCY |
Director |
2023-06-14 |
15,493 |
|
0 |
Premium* |
|
Immunome Inc. |
IMNM |
Director |
2023-11-07 |
7,615 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
850 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 29 of 34
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2018-03-15 |
4 |
AS |
$84.73 |
$1,270,901 |
D/D |
(15,000) |
264,674 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2018-03-16 |
4 |
OE |
$38.59 |
$578,850 |
D/D |
15,000 |
311,106 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2018-03-16 |
4 |
AS |
$83.26 |
$1,248,854 |
D/D |
(15,000) |
296,106 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2022-03-10 |
4 |
AS |
$77.57 |
$1,163,550 |
D/D |
(15,000) |
338,569 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2022-03-10 |
4 |
OE |
$37.46 |
$561,900 |
D/D |
15,000 |
353,569 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2022-03-11 |
4 |
OE |
$37.46 |
$561,900 |
D/D |
15,000 |
353,569 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2022-03-11 |
4 |
AS |
$77.81 |
$1,167,150 |
D/D |
(15,000) |
338,569 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2023-02-10 |
4 |
AS |
$110.11 |
$1,651,650 |
D/D |
(15,000) |
320,324 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2023-02-10 |
4 |
OE |
$67.81 |
$1,017,150 |
D/D |
15,000 |
335,324 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2023-03-10 |
4 |
AS |
$92.28 |
$1,384,200 |
D/D |
(15,000) |
487,856 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2023-03-10 |
4 |
OE |
$67.81 |
$1,017,150 |
D/D |
15,000 |
502,856 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Director |
|
2024-02-08 |
4 |
OE |
$63.10 |
$946,500 |
D/D |
15,000 |
434,602 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Director |
|
2024-02-08 |
4 |
AS |
$89.77 |
$1,346,550 |
D/D |
(15,000) |
419,602 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Director |
|
2024-02-09 |
4 |
OE |
$63.10 |
$946,500 |
D/D |
15,000 |
434,602 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Director |
|
2024-02-09 |
4 |
AS |
$88.28 |
$1,324,200 |
D/D |
(15,000) |
419,602 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2017-03-15 |
4 |
D |
$92.50 |
$1,451,325 |
D/D |
(15,690) |
190,674 |
0 |
- |
|
IMUX |
Immunic Inc |
Director |
|
2017-06-13 |
4 |
B |
$3.00 |
$48,069 |
D/D |
16,000 |
55,119 |
2.39 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2008-02-29 |
4 |
OE |
$6.46 |
$116,280 |
D/D |
18,000 |
25,213 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2018-05-10 |
4 |
AS |
$89.59 |
$1,679,794 |
D/D |
(18,750) |
290,600 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2018-05-10 |
4 |
OE |
$38.59 |
$723,563 |
D/D |
18,750 |
309,350 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2018-05-11 |
4 |
AS |
$88.42 |
$1,657,856 |
D/D |
(18,750) |
290,600 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2018-05-11 |
4 |
OE |
$38.59 |
$723,563 |
D/D |
18,750 |
309,350 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2018-05-14 |
4 |
OE |
$38.59 |
$723,563 |
D/D |
18,750 |
309,350 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2018-05-14 |
4 |
AS |
$89.22 |
$1,672,851 |
D/D |
(18,750) |
290,600 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2018-05-15 |
4 |
AS |
$88.29 |
$1,655,434 |
D/D |
(18,750) |
290,600 |
0 |
- |
|
850 Records found
|
|
Page 29 of 34 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|